Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Sorrento Therapeutics Inc (NASDAQ:SRNE)

4.73
Delayed Data
As of 12:25pm ET
 +0.2299 / +5.11%
Today’s Change
4.25
Today|||52-Week Range
26.80
-45.70%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2011

2012

2013

2014
Revenue and IncomeNet Revenues529.2K583.8K460.1K3.8M
 
 
 
 
 
Cost of Goods Sold----4.4K1.2M
 
 
 
Depreciation And Amortization159.2K293.3K1.3M3.2M
 
 
 
 
 
 
Operating ExpensesGross Income-----834.7K-563.0K
 
 
 
General Expenses3.6M5.1M14.8M34.0M
 
 
 
 
 
Research And Development2.6M3.8M9.0M24.0M
 
 
 
 
 
Total Operating Expenses3.8M5.4M16.1M38.4M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-3.2M-4.9M-15.7M-34.5M
 
 
 
 
 
Extraordinary Charge0.000.00-6.0M-209.0K
 
 
 
Interest Expense On Debt0.000.00253.2K1.6M
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-3.2M-4.8M-21.9M-36.4M
 
 
 
 
 
Income Taxes0.000.000.00-1.7M
 
 
Net Income-3.2M-4.8M-21.9M-34.7M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS9.9M11.4M15.0M26.7M
 
 
 
 
 
Shares To Calculate EPS Diluted9.9M11.4M15.0M26.7M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.25-$0.50-$1.46-$1.30
 
 
 
 
 
EPS Diluted-$0.25-$0.50-$1.46-$1.30